As part of its 2018 operating grant, Alzheimer Europe will aim to:
- Provide a voice to people with dementia by carrying out an inventory and analysis of existing working groups of people with dementia, their membership, working methods and findings and producing a report with the findings and identified good practices
- Make dementia a European priority by comparing and analysing differences and commonalities contained in the priority actions and themes of national dementia strategies and providing a comparative report with the key findings
- Promote a rights-based approach to dementia by identifying the issues faced by people with dementia, carers and professional carers coming from ethnic, cultural and religious minorities as the priority of its European Dementia Ethics Network, carrying out an extensive literature review and analysis of existing initiatives on this subject and producing a report with the key findings and recommendations
- Support dementia research by developing an online database of phase II and phase III clinical trials on Alzheimer's disease and dementia, by continuing the development of its European Dementia Observatory and by organising a conference in Barcelona from 27-29 October with at least 500 participants from 30 European countries
- Strengthen the European dementia movement by carrying out a mapping exercise of organisations with an interest in dementia, developing a networking strategy and by organising the Alzheimer's Association Academy with capacity-building workshops for its national member organisations.
The activities undertaken as part of Alzheimer Europe’s 2018 Work Plan are fully aligned with key EU programmes and respond to the calls made by successive EU Presidencies for greater European collaboration on dementia. In particular, the organisation will ensure to respond to the detailed 2015 Council conclusions and support the work of the 2nd Joint Action on dementia and the Group of governmental experts on dementia.




In 2019, AIDS Action Europe (AAE) will continue the work that is described under its leading title of the FPA 2018 - 2021, Stronger Together, and that is based on the achievements of the activities in 2018. imwill implement its work programme in 2018. As a comprehensive NGO network of 421 NGOs, national networks, AIDS service organisations, and community based groups in 47 countries in the WHO European Region, AAE is a unique player with substantial added value for European policy making and programme implementation in the response to HIV/AIDS, TB and hepatitis.
The three main objectives of the work are
1. AAE contributes effectively to the HIV, TB and hepatitis response in Europe
2. AAE provides platforms to communicate and facilitate collaboration, networking, and linking and learning
3. Continuous improvement of network collaboration through governance and internal management.
Considering the epidemiological background and evidence, AAE will continue with regard to Objective I, to serve as the secretariat to the EU CSF, to monitor and contribute to policy developments, to coordinate the European HIV Legal Forum, and advocate for CS concerns. Objective 2 comprises improved bilingual communication and exchange, intensified social media communication, dissemination of 3rd health programme information and tools, support of national and regional affordability advocacy efforts and provision of capacity building activities. Eventually, objective III includes ensuring topic-related sub-network cooperation, overall governance by the AAE Steering Committee and implementation, monitoring, evaluation, follow-up and fundraising for the work programme. Herewith we will continue focusing on the following six core thematic areas identified by our members and partners:
- CBVCT
- Affordability
- Tackling legal barriers in the response to HIV, TB and hepatitis
- Criminalisation of HIV non-disclosure, exposure and transmission
- SRHR
- Tackling stigma and discrimination



The Correlation Network (CN) is a European civil society network and centre of expertise in the field of drug use, harm reduction and social inclusion.

Overall objective of this proposal:
Improve the access to and the quality of harm reduction services for People Who Use Drugs (PWUD), including other related vulnerable and marginalised people and to enhance policies and practices that increase social inclusion.

This is achieved by the following strategic objectives
- Strengthen the network and the collaboration with its members and partners through an adequate and solid organisational network structure
- Monitor developments and collect information and evidence in the field of drug use and harm reduction, by involving the expertise of civil society organisations
- Strengthen capacities of the various players in the field of drug use and harm reduction and facilitate exchange between network members and partners
- Advocate for full coverage of harm reduction programmes in Europe, addressing both health and social aspects.

All CN activities will pay specific attention to Hepatitis C, new drug trends and overdose prevention. Relevant CN outputs include : Sustainable network, Annual Monitoring Reports, Online knowledge and training hub, European Harm Reduction Conferences (2018/20), policy recommendations.

CN contributes to the Third Health Programme (THP) by promoting health (in particular harm reduction), prevent diseases (in particular drug-related diseases and infectious diseases such as HCV and HIV/AIDS), and foster supportive environments for healthy lifestyles (e.g. by reducing barriers to access health and social services).

CN contributes as well to the following THP priorities:
1.2. Drugs-related health damage, including information and prevention
1.3. HIV/AIDS, tuberculosis and hepatitis
2.2. Capacity-building against health threats in Member States, including, where appropriate, cooperation with neighbouring countries



In 2019, AE will:
• Ensure that the voices of people with dementia are duly included in all operating grant activities by involving its European Working Group of People with Dementia, organise at least three meetings of the group and collaborate closely with the 2nd Joint Action on Dementia and develop recommendations on dementia-friendly and dementia-inclusive initiatives
• Collect information on epidemiological studies carried out in European countries looking at the incidence and prevalence of MCI, AD and dementia, carry out a meta-analysis, calculate the estimated numbers of people with dementia in all Member States of the European Union c and publish a report of these findings in the 2019 edition of the Alzheimer Europe Yearbook.
• Identify the issues faced by people with dementia when participating in research as the priority of its European Dementia Ethics Network and carry out an extensive literature review on this subject, develop recommendations to promote a human rights based approach to the involvement of people with dementia in research and publish the recommendations with the findings of the literature review in a report.
• Continue with the development of its European Dementia Observatory, organise a conference in The Hague, Netherlands under the motto “Making valuable connections” from 22-25 October 2019 with the participation of at least 750 participants from 30 European countries and carry out an invetory of European and national treatment and management guidelines for dementia.
• Carry out a mapping exercise of its national organisations to understand their membership, staffing, funding as well as their activities and services and bring together representatives of the national Alzheimer associations for three networking meetings of the Alzheimer’s Association Academy.


The overall objective of Correlation – European Harm Reduction Network (C-EHRN) is to improve the access to and the quality of harm reduction services for PWUDs including other related vulnerable and marginalised people and to enhance policies and practices that increase social inclusion. The strategic objectives, activities and operational targets of C-EHRN are organised in four different pillars: Network, Monitoring and data collection, Capacity building and Advocacy. The network pillar strives to improve and strengthen the overall structure of C-EHRN and creates the prerequisites for the implementation of actions in the other three content-based pillars. These focus on drug use and harm reduction (HR) in general and more specifically on HCV in substance users, new drug trends and drug using patterns and overdose prevention. Activities within the various pillars inform and contribute to each other. C-EHRN activities in 2020 build upon the developments and achievements of the previous years and respond to current challenges. In short, this includes: Network: Further expansion and strengthening of the network, by utilizing the expertise of itsmembers and by involving them actively in the development and the implementation of C-EHRN activities. Monitoring: Enhance the content and the implementation of the C-EHRN monitoring tool, by evaluating the monitoring process and results of 2019 and by improving coverage, outcomes and applicability of the tool. C-EHRN Focal Points (FPs) and our members of the Scientific Expert Group (SEG) will play a major in this evaluation process. Capacity Building: Ongoing collection of resources and tools for the online knowledge and training hub and development of thematic papers, materials and development and organisation of trainings. Advocacy: Identify and analyse relevant policy developments and formulate an updated advocacy strategy for 2020 and 2021. C-EHRN activities and policy recommendations.
